EurekaMag.com logo
+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Recurrence rate of CMV retinitis in eyes with the ganciclovir implant and silicone oil



Recurrence rate of CMV retinitis in eyes with the ganciclovir implant and silicone oil



Investigative Ophthalmology & Visual Science 38(4 PART 1-2): S741




(PDF emailed within 1 workday: $29.90)

Accession: 033119011

Download citation: RISBibTeXText



Related references

Use of intra-ocular ganciclovir in eyes with CMV retinitis previously having undergone silicone oil tamponade of a retinal detachment. TENTH INTERNATIONAL CONFERENCE ON AIDS, INTERNATIONAL CONFERENCE ON STD [Author] Tenth International Conference on AIDS and the International Conference on STD, Vol 2; The global challenge of AIDS: Together for the future : 2) 125, 1994

Treating cytomegalovirus retinitis-related retinal detachment by combining silicone oil tamponade and ganciclovir implant. Ophthalmic Surgery and Lasers 33(2): 135-139, 2002

The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial. American Journal of Ophthalmology 131(4): 457-467, April, 2001

High dose intravitreal ganciclovir and foscarnet in vitreous and silicone oil filled eyes for the treatment of cytomegalovirus retinitis in aids patients. Investigative Ophthalmology & Visual Science 36(4): S181, 1995

Safety and efficacy of an intravitreal ganciclovir implant after pars plana vitrectomy and silicone oil tamponade in patients with AIDS and CMV retinitis. IOVS 39(4): S135, March 15, 1998

Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. New England Journal of Medicine 340(14): 1063-1070, 1999

Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group. New England Journal of Medicine 337(2): 83-90, 1997

Treatment of rhegmatogenous retinal detachment due to cytomegalovirus retinitis with combination pars plana vitrectomy/silicone oil tamponade and sustained-release ganciclovir implant. IOVS 39(4): S135, March 15, 1998

Ganciclovir implant and oral ganciclovir vs cidofovir for cytomegalovirus retinitis in patients with AIDS The ganciclovir cidofovir cytomegalovirus retinitis trial. IOVS 42(4): S567, March 15, 2001

Complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis: the Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial. Retina 24(1): 41-50, 2004

Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. New England Journal of Medicine 340(14): 1063-1070, April 8, 1999

Bioavailability of ganciclovir from a sustained release ganciclovir intraocular implant in silicone oil an in vitro study. ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 4619, 2003

Recurrence rate of CMV retinitis in patients who have undergone pars plana vitrectomy and silicone oil injection. Investigative Ophthalmology & Visual Science 36(4): S321, 1995

Genotypic analysis of cytomegalovirus retinitis poorly responsive to intravenous ganciclovir but responsive to the ganciclovir implant. American Journal of Ophthalmology 135(1): 20-25, January, 2003